MedTrace Logo

Markers of Paroxysmal Atrial Fibrillation in Esophageal Holter Electrocardiography

NCT01436344 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-07-23

No results posted yet for this study

Summary

With the use of esophageal Holter electrocardiography (eECG), the investigators will look for surrogate markers of paroxysmal atrial fibrillation. To do so, the investigators will record eECGs in patients with known paroxysmal atrial fibrillation but at the time of eECG-recording in sinus rhythm. To identify markers, the eECGs of those patients will be compared to a group of controls in sinus rhythm without atrial fibrillation. The investigators hypothesis is that it is possible to identify surrogate markers in patients with paroxysmal atrial fibrillation.

Conditions

Sponsors & Collaborators

  • Swiss Commission for Technology and Innovation

    collaborator OTHER

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Rolf Vogel, MD, PhD · Bern University Hospital

  • Andreas D Haeberlin, MD · Bern University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-03-31
Completion
2015-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01436344 on ClinicalTrials.gov